Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-25 @ 3:03 AM
Ignite Modification Date: 2025-12-26 @ 1:42 AM
NCT ID: NCT02995733
Description: SAE was defined as any event that resulted in death, hospitalization, persistent/significant disability, or congenital anomaly/birth defect; or was otherwise life-threatening. Data on adverse events that resulted in hospitalization or death were obtained by participant report or site report. Adverse events were not monitored/assessed with regard to the specific Adverse Event Term.
Frequency Threshold: 0
Time Frame: From enrollment to study completion, an average of 15 months per participant.
Study: NCT02995733
Study Brief: Patient Empowered Strategy to Reduce Asthma Morbidity in Highly Impacted Populations; PeRson EmPowered Asthma RElief
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Usual Care Provider-enhanced usual care arm; no change in asthma management 4 None 74 611 0 611 View
PARTICS addition of PARTICS strategy - Patient Activated Reliever-Triggered Inhaled CorticoSteroid (PARTICS) using QVAR . Patient will use inhaled corticosteroid at time of rescue inhaler use PARTICS using QVAR: Patient takes inhaled corticosteroid at the time of rescue inhaler use 3 None 75 609 0 609 View
Serious Events(If Any):

Serious Events

Term Type Organ System Vocab View
Asthma NON_SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders None View
Cardiac events NON_SYSTEMATIC_ASSESSMENT Cardiac disorders None View
Gastrointestinal disorders NON_SYSTEMATIC_ASSESSMENT Gastrointestinal disorders None View
Infections and infestations NON_SYSTEMATIC_ASSESSMENT Infections and infestations None View
Musculoskeletal and connective tissue disorders NON_SYSTEMATIC_ASSESSMENT Musculoskeletal and connective tissue disorders None View
Nervous system disorders NON_SYSTEMATIC_ASSESSMENT Nervous system disorders None View
Renal/urinary disorders NON_SYSTEMATIC_ASSESSMENT Renal and urinary disorders None View
Reproductive system and breast disorders NON_SYSTEMATIC_ASSESSMENT Reproductive system and breast disorders None View
Skin and subcutaneous tissue disorders NON_SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders None View
Substance abuse NON_SYSTEMATIC_ASSESSMENT Psychiatric disorders None View
Vascular disorders NON_SYSTEMATIC_ASSESSMENT Vascular disorders None View
Psychiatric disorders NON_SYSTEMATIC_ASSESSMENT Psychiatric disorders None View
Respiratory, thoracic, mediastinal disorders NON_SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders None View
Unclassified elsewhere NON_SYSTEMATIC_ASSESSMENT General disorders None View
Hematology/oncology NON_SYSTEMATIC_ASSESSMENT Blood and lymphatic system disorders None View
Immune system disorders NON_SYSTEMATIC_ASSESSMENT Immune system disorders None View
Metabolism and nutrition disorders NON_SYSTEMATIC_ASSESSMENT Metabolism and nutrition disorders None View
Other Events(If Any):